LHLilin Huang

Lilin Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lilin Huang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and internal validation of a nomogram for predicting flexible bronchoscopy utilization in children with lobar pneumonia caused by Mycoplasma pneumoniae: a single-center retrospective cohort study

    by Lilin Huang, Jing Li, Cuilan Liu, Xiaole Yang, Hainan Xu

    Background: The recent resurgence of Mycoplasma pneumoniae (MP) pneumonia has increased the number of children with lobar pneumonia who may receive flexible bronchoscopy (FB), yet the decision to perform FB remains subjective, and no quantitative tool exists for this specific high-risk subgroup. This study aimed to develop and internally validate a nomogram to predict FB utilization in children with MP-related lobar pneumonia using routine admission indicators to support real-time bedside decision-making. Methods: This single-center retrospective study included 345 children (aged 1 month–18 years) with serology-confirmed MP-related lobar pneumonia (January 2022–March 2025); those with congenital heart disease, immunodeficiency, or plastic bronchitis were excluded. Patients were divided into FB (n=171) and non-FB (n=174) groups based on whether FB was performed. Laboratory predictors were restricted to values obtained within 72 hours of admission and before the FB decision. FB was recommended if symptoms or signs persisted after ≥72 hours of standard therapy. Multivariate logistic regression was used to identify predictors, and a nomogram was constructed and internally validated by 10-fold cross-validation. Model performance was assessed by area under the curve (AUC), calibration, and decision curve analysis (DCA). Results: Viral coinfection [odds ratio (OR) =23.271, 95% confidence interval (CI): 9.299–64.900, PConclusions: The nomogram showed modest ability to predict FB use in this single-center cohort, but its clinical utility for identifying children with lobar pneumonia caused by MP who truly require FB remains uncertain.

  • Open Access

    Clinical Characteristics and Predictive Value of the Lactate Dehydrogenase‐to‐Lymphocyte Ratio in Infants With Pneumocystis jirovecii Pneumonia: A Retrospective Study

    by Lilin Huang

    Background and Aims: Pneumocystis jirovecii pneumonia (PCP) is a life‐threatening fungal infection in immunocompromised children. The aims of this study were to observe the clinical characteristics and assess the predictive value of the lactate dehydrogenase (LDH)‐to‐total lymphocyte count ratio (LTLR) for early identification of PCP in infants under 1 year old with interstitial pneumonia. Methods: We retrospectively evaluated medical data of infants with PCP and viral or Mycoplasma pneumoniae pneumonia during the period from January 1, 2016 until December 31, 2021 at Guangdong Women and Children Hospital. Continuous variables were compared using the Mann–Whitney U test. Categorical variables were analyzed with the χ 2 test or Fisher's exact test, as appropriate. A receiver operating characteristic (ROC) curve was used to evaluate the predictive value of the LTLR for distinguishing PCP from other pathogen‐related pneumonia. Results: Thirteen non‐HIV‐infected infants with PCP and 50 infants with viral or Mycoplasma pneumoniae pneumonia were enrolled. Compared with the control group, the PCP group had significantly greater rates of underlying conditions. Cytomegalovirus coinfection was more common in the PCP group. Laboratory findings revealed significantly lower white blood cell counts, total lymphocyte counts, and albumin levels, alongside elevated C‐reactive protein, lactate dehydrogenase, and LTLR in the PCP group. PCP patients also had higher rates of respiratory support, reinfection, and mortality, as well as longer hospital stays. LTLR was positively correlated with the length of hospital stay. ROC curve analysis revealed that the LTLR had an area under the curve (AUC) of 0.845 (95% CI: 0.715–0.974) for predicting PCP, with a sensitivity of 69.2% and specificity of 94.0% at a cutoff value of > 441.82. Conclusion: Early diagnosis of PCP in infants is difficult. Infants with PCP are usually immunocompromised and prone to viral coinfection. LTLR shows promise as a predictive biomarker for PCP in non‐HIV‐infected infants.

  • Open Access

    Predictive value of the serum procalcitonin level for fulminant virus-associated encephalopathy

    by Lilin Huang, Xiaole Yang, Jing Li, Shumei Peng

    Fulminant virus-associated encephalopathy (VAE) is a rare complication of viral infection that presents as acute brain dysfunction and requires respiratory support and/or vasoactive agents. However, the mechanism of VAE is undetermined. The mortality rate is high since there is no specific treatment for fulminant VAE. The aim of this study was to identify risk factors for children with fulminant VAE on the basis of clinical data since timely recognition and treatment might be needed to improve the poor prognosis. This retrospective study included children with fulminant VAE who were diagnosed between June 2018 and October 2023 in the PICU of Guangdong Women and Children Hospital. Clinical data were analyzed, and receiver operating characteristic (ROC) curve analysis was performed to determine the prognostic value of the selected variables. Twenty-three children with fulminant VAE were included and divided into a survival group (n = 16) and a nonsurvival group (n = 7). The mortality rate of patients with fulminant VAE was 30.8%. Compared with the survival group, the nonsurvival group had higher incidences of shock 48 h after onset, a higher acute necrotizing encephalopathy severity score (ANE-SS), higher procalcitonin (PCT) levels, and lower platelet counts (p < 0.05). The serum PCT level was significantly higher in the children with shock than in those without shock (p = 0.015). The serum PCT concentration was positively correlated with the ANE-SS (correlation coefficient 0.544, p < 0.039). Combined immunotherapies might help to decrease PCT levels in some children. Low PCT levels might be related to a good outcome. The area under the curve (AUC) for PCT used to predict death in patients with fulminant VAEs was 0.821 (95% CI 0.626–1.00). The sensitivity and specificity of PCT > 101.58 ng/ml for predicting death in patients with fulminant VAE were 57.1% and 100.0%, respectively. Patients with fulminant VAE deteriorate rapidly and are at high risk of death if they develop shock within 48 h after onset, exhibit extremely elevated serum PCT levels, or have decreased platelet counts. The serum PCT level might predict the death outcome of patients with fulminant VAE.


  • Open Access

    Case report: Bilateral parotid abscess in a 54-day-old infant

    by Lilin Huang, Xiaole Yang, Shumei Peng, Ronghan Li

    Acute parotid abscess (PA) is rare in children and is prone to occur in neonates or preterm infants with high-risk factors. Sporadic cases of unilateral PA have been reported in older children. Here, we report a case of a 54-day-old child who developed bilateral PA due to Staphylococcus aureus infection. The infant showed bilateral cervical lymphadenopathy initially following a 13-valent pneumococcal conjugate vaccine (PCV13). However, bilateral PA developed 6 h after he was diagnosed with lymphadenitis on Day 9 of illness. Rapid PA progression from cervical lymphadenitis is rare. He recovered quickly under treatment with appropriate antibiotics based on susceptibility testing and surgical incision and drainage.


  • Open Access

    Case Report: Lower Limb Muscle Weakness in a Child With Kawasaki Disease

    by Lilin Huang, Shumei Peng, Jing Li, Danyu Xie

    Kawasaki disease (KD) is a systemic vasculitis that may impact multiple organ systems in children. Myositis is an unusual presentation of KD that presents with muscle weakness. To date, a few pediatric patients with KD and myositis have been reported. Diffuse muscle weakness involving the 4 limbs was the most common presentation in these children. However, isolated lower limb involvement was rarely reported before. Here, we report lower limb muscle weakness in an 18-month-old child with KD. He presented with fever, rash, conjunctival injection, peeling over fingers and toes, and progressive muscle weakness of the lower limbs. Muscle enzymes were normal, but electromyography indicated myositis. The symptom of fever was relieved quickly by intravenous immunoglobulin and aspirin, which were ineffective for myositis. However, lower limb muscle weakness fully recovered 5 days after prednisolone treatment. This rare case might add value to the growing literature exploring the association of KD with myositis.


  • [Effect of ZhuLian's type Ⅱ inhibition needling technique on endocrine metabolism in rats with polycystic ovary syndrome and insulin resistance].

    by Li-Lin Huang, Xiao-Jun Zhao, Wei Mai, Cai He, Yu-Shan Fan

    To observe the effect of ZhuLian's type Ⅱ inhibition needling technique on sex hormones, insulin resistance and ovarian morphology in rats with polycystic ovary syndrome (PCOS), so as to explore its mechanism on regulating endocrine and metabolic dysfunction of PCOS. Twenty-four female SD rats were randomly divided into control, model and ZhuLian acupuncture groups (n=8 in each group). The PCOS model was established by continuous gavage of letrozole combined with high-fat diet. Rats of the ZhuLian acupuncture group were stimulated at "Guanyuan"(CV4) and bilateral "Guilai"(ST29), "Zusanli"(ST36), "Sanyinjiao"(SP6), and "Fenglong"(ST40) by ZhuLian's type Ⅱ inhibition needling technique for 30 min, continuously intervented for 28 days. The body weight was measured before and after modeling and after intervention. The ovarian volume was calculated. HE staining was used to observe the changes of ovarian histology. Plasma levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and fasting insulin (FINS) were measured by ELISA. LH/FSH ratio and insulin resistance index (HOMA-IR) were calculated. After modeling, the rats' body weight and the ovarian volume were increased (PPPPPP<0.05) in the ZhuLian acupuncture group than in the model group. ZhuLian's type Ⅱ inhibition needling technique can improve the endocrine and metabolic disorders in PCOS rats, which may be related to the regulation of endocrine system.

  • Open Access

    Case Report: Fatal Neurotoxicity Following Resmethrin Poisoning in a Child

    by Lilin Huang, Shumei Peng, Ronghan Li, Dongping Huang, Danyu Xie

    Resmethrin, a type I pyrethroid insecticide, can activate sodium channels, causing neurotoxicity in both mammals and insects. Possible routes of poisoning include inhalation, dermal contact and ingestion. There are no specific symptoms for resmethrin poisoning. Until now, no antidote has been available for resmethrin. Resmethrin poisoning is rarely reported in children. Here, we report a fatal case of resmethrin poisoning that might have been caused by accidental ingestion by a 26-month-old child. He presented with neurotoxic symptoms that included vomiting, recurrent seizures, and coma. The cranial CT showed extensive lesions of low intensity in the bilateral white matter, thalamus, brainstem, and cerebellum. Lumbar punctures showed increased intracranial pressure (ICP > 25 mmHg). Cerebrospinal fluid (CSF) tests revealed that protein was elevated to 289.2 mg/dL without pleocytosis. Resmethrin was detected in his blood by liquid chromatography-mass spectrometry, which confirmed the diagnosis of resmethrin poisoning. The child developed brain stem herniation and then was declared brain dead at the 77th h after admission. Resmethrin poisoning can be fatal, and it requires immediate diagnosis and treatment. Previous studies reported that cranial CT and CSF analyses were all normal in patients with pyrethroid poisoning. This case might extend the knowledge of neuroimaging and CSF analysis in children with resmethrin poisoning.


  • Open Access

    Chitin-rich heteroglycan from Sporothrix schenckii sensu stricto potentiates fungal clearance in a mouse model of sporotrichosis and promotes macrophages phagocytosis

    by Lilin Huang, Jing Zhang, Weian Du, Zixian Liang, Meirong Li, Rong Wu, Sanmei Chen, Xuchu Hu, Huaiqiu Huang

    Background: Fungal cell wall polysaccharides maintain the integrity of fungi and interact with host immune cells. The immunomodulation of fungal polysaccharides has been demonstrated in previous studies. However, the effect of chitin-rich heteroglycan extracted fromSporothrix schenckiisensu strictoon the immune response has not been investigated.Results: In this study, chitin-rich heteroglycan was extracted fromS. schenckiisensu stricto, and immunomodulation was investigated via histopathological analysis of skin lesions in a mouse model of sporotrichosis and evaluation of the phagocytic function and cytokine secretion of macrophages in vitro. The results showed that the skin lesions regressed and granulomatous inflammation was reduced in infected mice within 5 weeks. Moreover, heteroglycan promoted the fungal phagocytosis by macrophages and modulated the cytokine secretion. Heteroglycan upregulated TNF-α expression early at 24 h and IL-12 expression late at 72 h after incubation, which might result from moderate activation of macrophages and contribute to the subsequent adaptive immune response.Conclusions: Chitin-rich heteroglycan extracted fromS. schenckiisensu strictopotentiated fungal clearance in a mouse model of sporotrichosis. Moreover, chitin-rich heteroglycan promoted fungus phagocytosis by macrophages and modulated cytokines secretion. These results might indicate that chitin-rich heteroglycan could be considered as an immunomodulator used in the treatment of sporotrichosis.